alzheimer's%20disease%20-and-%20dementia
ALZHEIMER'S DISEASE AND DEMENTIA
Dementia is a clinical syndrome characterized by impairment of multiple higher cortical functions that include memory, orientation, thinking, comprehension, calculation, capacity for learning, language, judgment,  executive function and visuo-spatial function. It is usually accompanied or preceded by deterioration in emotional control, social behavior or motivation.
Alzheimer's disease is the most common cause of dementia. Sporadic cases usually present after >60 year while familial types are rare and present in <60 year of age (early-onset dementia).
Short-term memory loss is the most common early symptom. Other spheres of cognitive impairment manifest after several years.

Alzheimer's Disease and Dementia Drug Information

Drug Information

Indication: Patients w/ moderate to severe Alzheimer's disease.

Indication: Mild, moderate & severe Alzheimer's dementia.

Indication: Mild to moderately severe dementia of the Alzheimer type.

Indication: Improvement of blood circulation & promotion of general health.

Indication: Mild, moderate & severe Alzheimer's dementia.

Indication: Cerebral circulatory insufficiency & its functional manifestation (memory loss, decrease in intellectual c...

Indication: Mild to moderately severe dementia associated w/ Alzheimer's or Parkinson's disease & severe dementia asso...

Indication: Traditionally used to improve blood circulation.

Indication: Cerebral circulatory insufficiency & its functional manifestation (memory loss, decrease in intellectual c...

Indication: Mental disorders caused by CVA, head trauma & ageing.

1  /  4
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Psychiatry - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
3 days ago
Chest pain appears to be the principal complaint of patients hospitalized with a first myocardial infarction (MI), particularly among those in the youngest age group, a study has found.
Jairia Dela Cruz, 16 Sep 2020
In patients with heart failure with reduced ejection fraction (HFrEF) receiving angiotensin-converting-enzyme (ACE) inhibitors, high dosing confers benefits for the risk of death or hospitalization that are similar to that obtained with lower dosing, according to a systematic review and meta-analysis.
Pearl Toh, 3 days ago
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
4 days ago
Women with pre-eclampsia are at higher risk of developing heart failure, a study suggests.